Devoy Eoin J, Jabari Erfan, Kotsanos George, Choe Robert H, Fisher John P
Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland, USA.
Tissue Eng Part B Rev. 2025 Jun;31(3):248-265. doi: 10.1089/ten.TEB.2024.0126. Epub 2024 Aug 19.
Bone defects because of age, trauma, and surgery, which are exacerbated by medication side effects and common diseases such as osteoporosis, diabetes, and rheumatoid arthritis, are a problem of epidemic scale. The present clinical standard for treating these defects includes autografts and allografts. Although both treatments can promote robust regenerative outcomes, they fail to strike a desirable balance of availability, side effect profile, consistent regenerative efficacy, and affordability. This difficulty has contributed to the rise of bone tissue engineering (BTE) as a potential avenue through which enhanced bone regeneration could be delivered. BTE is founded upon a paradigm of using biomaterials, bioactive factors, osteoblast lineage cells (ObLCs), and vascularization to cue deficient bone tissue into a state of regeneration. Despite promising preclinical results, BTE has had modest success in being translated into the clinical setting. One barrier has been the simplicity of its paradigm relative to the complexity of biological bone. Therefore, this paradigm must be critically examined and expanded to better account for this complexity. One potential avenue for this is a more detailed consideration of osteoclast lineage cells (OcLCs). Although these cells ostensibly oppose ObLCs and bone regeneration through their resorptive functions, a myriad of investigations have shed light on their potential to influence bone equilibrium in more complex ways through their interactions with both ObLCs and bone matrix. Most BTE research has not systematically evaluated their influence. Yet contrary to expectations associated with the paradigm, a selection of BTE investigations has demonstrated that this influence can enhance bone regeneration in certain contexts. In addition, much work has elucidated the role of many controllable scaffold parameters in both inhibiting and stimulating the activity of OcLCs in parallel to bone regeneration. Therefore, this review aims to detail and explore the implications of OcLCs in BTE and how they can be leveraged to improve upon the existing BTE paradigm.
由于年龄、创伤和手术导致的骨缺损,因药物副作用以及骨质疏松症、糖尿病和类风湿性关节炎等常见疾病而加剧,已成为一个具有流行规模的问题。目前治疗这些缺损的临床标准包括自体移植和异体移植。尽管这两种治疗方法都能促进显著的再生效果,但它们未能在可用性、副作用特征、一致的再生效果和可承受性之间达成理想的平衡。这一难题促使骨组织工程(BTE)兴起,成为实现增强骨再生的潜在途径。BTE基于一种范式,即利用生物材料、生物活性因子、成骨细胞系细胞(ObLCs)和血管生成来促使缺损的骨组织进入再生状态。尽管临床前结果令人鼓舞,但BTE在转化为临床应用方面取得的成功有限。一个障碍是其范式相对于生物骨的复杂性过于简单。因此,必须对这一范式进行严格审视并加以扩展以更好地考虑这种复杂性。实现这一点的一个潜在途径是更详细地考虑破骨细胞系细胞(OcLCs)。尽管这些细胞表面上通过其吸收功能与ObLCs和骨再生相对立,但大量研究揭示了它们通过与ObLCs和骨基质的相互作用以更复杂的方式影响骨平衡的潜力。大多数BTE研究尚未系统评估它们的影响。然而,与该范式相关的预期相反,一些BTE研究表明这种影响在某些情况下可以增强骨再生。此外,许多工作阐明了许多可控支架参数在抑制和刺激OcLCs活性以及促进骨再生方面的作用。因此,本综述旨在详细阐述并探讨OcLCs在BTE中的意义以及如何利用它们来改进现有的BTE范式。